The HSPA1L Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma cell line. This product disrupts the HSPA1L gene using CRISPR/Cas9-mediated gene disruption, generating a heterogeneous pool of cells with targeted loss-of-function mutations. As polyclonal knockout cells, the population maintains genetic diversity, which can be advantageous for studying overall phenotypic consequences of HSPA1L ablation without clonal bias. This model provides a powerful tool for investigating chaperone-mediated stress responses in a cancer-relevant epithelial background.
A-549 cells are alveolar basal epithelial cells originally isolated from the lung adenocarcinoma of a 58-year-old Caucasian male. They are widely used as a model for lung adenocarcinoma biology, drug response, and oncogenic signaling. These adherent cells retain epithelial morphology and express characteristic markers, making them suitable for mechanistic studies in pulmonary cancer research. The A-549 line’s p53 wild-type status and basal activation of stress-responsive pathways render it a relevant context for exploring heat shock protein functions.
HSPA1L encodes a member of the HSP70 family of molecular chaperones that facilitates protein folding, prevents aggregation, and triages misfolded proteins under cellular stress. Its expression is primarily regulated by the heat shock transcription factor HSF1 in response to elevated temperatures, oxidative stress, or proteotoxic insults. HSPA1L collaborates with co-chaperones such as HSP40 (DNAJ proteins) and nucleotide exchange factors like BAG family members, and it directs substrates to the E3 ubiquitin ligase CHIP (STUB1) for degradation when refolding fails. Additionally, HSPA1L interacts with HSP90 and modulates apoptosis by impacting regulators such as BAX. Through these interactions, HSPA1L occupies a central node in the chaperone network that balances protein homeostasis and cell survival.
In A-549 cells, disruption of HSPA1L may compromise the cellular capacity to manage proteotoxic stress, leading to accumulation of misfolded proteins and heightened sensitivity to stressors. Given the high metabolic demands and secretory activity of adenocarcinoma cells, chaperone networks are often rewired to support tumor growth. Therefore, HSPA1L knockout can uncover vulnerabilities in protein quality control pathways specific to lung cancer. This model also enables dissection of the interplay between HSF1-driven stress responses and apoptotic signaling, as well as evaluation of synthetic lethal interactions with chemotherapeutic agents or proteasome inhibitors.
Researchers can employ these polyclonal knockout cells in a variety of assays including western blotting and RT-qPCR to verify HSPA1L disruption and downstream effects, immunofluorescence to monitor subcellular localization of client proteins, and co-immunoprecipitation to map chaperone complexes. Stress challenge assays??such as heat shock, oxidative stress, or endoplasmic reticulum stress induction??combined with flow cytometry for apoptosis allow detailed phenotypic profiling. The model is particularly suited for screening modulators of the heat shock response, investigating protein misfolding disease mechanisms, and exploring therapeutic strategies for lung adenocarcinoma. For further technical details or to discuss custom applications, please contact Ascent Research.
